STOCK TITAN

Windward Bio's Omar Khwaja holds 642,136 shares

Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
3

Rhea-AI Filing Summary

As of November 12, 2026, Windward Bio Group AG (WWB) Chief Medical Officer Omar Khwaja reported direct ownership of 642,136 common shares and an option covering 318,830 common shares.

The option has a $0.02 exercise price and expires April 30, 2036. It vested or will vest in 36 equal monthly installments on the last day of each relevant month, beginning April 30, 2026, subject to Khwaja’s continuous service on each vesting date.

Insider Khwaja Omar
Role Chief Medical Officer
Type Security Shares Price Value
Holding Employee Share Option (Right to Buy) F2, F1 -- -- --
Holding Common Shares -- -- --
Holdings: Employee Share Option (Right to Buy) — 318,830 options (Direct); Common Shares — 642,136 shares (Direct)
Footnotes (2)
  1. F1. This option vested or will vest in 36 equal monthly installments on the last day of the relevant month commencing on April 30, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
  2. F2. The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.
Direct common shares 642,136 shares Omar Khwaja’s reported holdings as of November 12, 2026
Option underlying shares 318,830 shares Employee share option held directly
Exercise price $0.02 per share The footnote states the price is in U.S. dollars
Option expiration April 30, 2036 Expiration date of the employee share option
Vesting installments 36 monthly installments Beginning April 30, 2026, subject to continuous service on each vesting date
Employee Share Option (Right to Buy) technical
"Employee Share Option (Right to Buy) covering 318,830 Common Shares"
exercise price financial
"The exercise price is in US Dollars"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
monthly installments technical
"vest or will vest in 36 equal monthly installments"
Monthly installments are regular, fixed payments made each month to gradually pay off a larger amount, such as a loan or purchase. Think of it like paying for a big item in small, manageable parts instead of all at once. For investors, understanding installment payments helps gauge how debts are structured and how they might affect financial stability or cash flow over time.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many WWB common shares does Omar Khwaja report holding?

Omar Khwaja reported direct ownership of 642,136 common shares as of November 12, 2026.

What are the terms of Omar Khwaja’s WWB option?

The option covers 318,830 common shares, has a $0.02 exercise price and expires April 30, 2036. It vested or will vest in 36 equal monthly installments beginning April 30, 2026, subject to his continuous service on each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Khwaja Omar

(Last)(First)(Middle)
C/O WINDWARD BIO GROUP AG
AESCHENPLATZ 6

(Street)
BASEL4052

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
11/12/2026
3. Issuer Name and Ticker or Trading Symbol
WINDWARD BIO GROUP AG [ WWB ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Medical Officer
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares642,136D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Share Option (Right to Buy) (1)04/30/2036Common Shares318,830$0.02(2)D
Explanation of Responses:
1. This option vested or will vest in 36 equal monthly installments on the last day of the relevant month commencing on April 30, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
2. The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.122 to CHF 1.00 as of November 6, 2026.
/s/ Scott Applebaum, Attorney-in-Fact11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Keep reading